- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: International Journal of Molecular Sciences 21.6 (2020): 2027.
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2020
- Creator
-
Torres, Sandra
Abdullah, Zeinab
Brol, Maximilian J.
Hellerbrand, Claus
Fernandez, Mercedes
Fiorotto, Romina
Klein, Sabine
Königshofer, Philipp
Liedtke, Christian
Lotersztajn, Sophie
Nevzorova, Yulia A.
Schierwagen, Robert
Reiberger, Thomas
Uschner, Frank Erhard
Tacke, Frank
Weiskirchen, Ralf
Trebicka, Jonel
- DOI
-
10.3390/ijms21062027
- URN
-
urn:nbn:de:bvb:29-opus4-204757
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Torres, Sandra
- Abdullah, Zeinab
- Brol, Maximilian J.
- Hellerbrand, Claus
- Fernandez, Mercedes
- Fiorotto, Romina
- Klein, Sabine
- Königshofer, Philipp
- Liedtke, Christian
- Lotersztajn, Sophie
- Nevzorova, Yulia A.
- Schierwagen, Robert
- Reiberger, Thomas
- Uschner, Frank Erhard
- Tacke, Frank
- Weiskirchen, Ralf
- Trebicka, Jonel
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2020
Other Objects (12)
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Established liver cell lines: are you sure to have the right ones?
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Resveratrol: Is It Really Good for Liver Health?
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Established liver cell lines: are you sure to have the right ones?
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Resveratrol: Is It Really Good for Liver Health?
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Established liver cell lines: are you sure to have the right ones?
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Resveratrol: Is It Really Good for Liver Health?